MINIALO-VELCADE2005: A Study of Bortezomib (Velcade) Treated Multiple Myeloma Patients Pre and Post Allogeneic Haematopoietic Progenitor Cell Transplant With no Myeloablative Conditioning

This study is currently recruiting participants.

Study NCT00564200 Information provided by PETHEMA Foundation

First Received: November 26, 2007 Last Updated: December 12, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	November 2012
Estimated Primary Completion Date:	July 2012 (Final data collection date for primary outcome measure)